Issued 2026-09-16 at $1839.71 · now $1839.71 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, MELI has typically landed between $1506.38 and $2224.60 — a range of −18.1% to +20.9% from the issuance price $1839.71.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
4,784 overlapping 1 month windows · 2007-08-10 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($1839.71) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where MELI has typically landed a month from the 2026-09-16 close of $1,840 — the range is history, not a prediction.
- now $1,840 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $1,842 (+0.1%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $1,701–$1,982
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $1,506–$2,225
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2007-12-28 | −54.2% | −54.2% | +0.0% |
| 2008-10-13 | −51.1% | −51.1% | +2.1% |
| 2008-09-26 | −50.7% | −50.7% | +0.0% |
| 3 best | |||
| 2007-11-27 | +83.1% | +0.0% | +83.1% |
| 2007-11-28 | +80.7% | −2.7% | +80.7% |
| 2007-11-26 | +77.0% | −0.1% | +77.0% |
4,784 overlapping windows · 2007-08-10 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-11 | Melamud Marcelo | officer | Purchase | 125 @ $1604.62 | $200K | +111.3% of holding | +14.2% | not yet — horizon still open | 237 | Form 4 · filed 4 days after the trade |
| 2026-05-22 | Aguzin Alejandro Nicolas | director | Purchase | 505 @ $1656.10 | $836K | +10.4% of holding | +1.1% | not yet — horizon still open | 5,355 | Form 4 · filed 4 days after the trade |
| 2026-05-22 | Aguzin Alejandro Nicolas | director | Purchase | 95 @ $1655.01 | $157K | +2.0% of holding | +1.1% | not yet — horizon still open | 4,850 | Form 4 · filed 4 days after the trade |
| 2026-02-27 | Melamud Marcelo | officer | Purchase | 57 @ $1755.77 | $100K | +103.6% of holding | −0.2% | −0.9% | 112 | Form 4 · filed 3 days after the trade |
| 2025-12-12 | Dubugras Henrique Vasoncelos | director | Sale | 845 @ $2028.14 | $1.7M | −100.0% of holding | +2.7% | −27.6% | 0 | Form 4 · filed 3 days after the trade |
| 2025-12-11 | Calemzuk Emiliano | director | Sale | 45 @ $2027.37 | $91K | −14.9% of holding | +1.7% | −28.6% | 257 | Form 4 · filed 1 day after the trade |
| 2025-12-09 | Tolda Stelleo | director | Sale | 246 @ $2047.88 | $504K | −100.0% of holding | +3.1% | −31.0% | 0 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
20 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-12 | Tolda Stelleo | director | Award / grant | 94 | 94 | Form 4 |
| 2026-06-12 | Aguzin Alejandro Nicolas | director | Award / grant | 94 | 5,449 | Form 4 |
| 2026-06-12 | Calemzuk Emiliano | director | Award / grant | 94 | 94 | Form 4 |
| 2026-06-12 | Dubugras Henrique Vasoncelos | director | Award / grant | 94 | 94 | Form 4 |
| 2026-06-12 | Lawson Martin R | director | Award / grant | 94 | 4,230 | Form 4 |
| 2026-06-12 | Sanders Richard A | director | Award / grant | 94 | 508 | Form 4 |
| 2026-06-12 | SEGAL SUSAN | director | Award / grant | 94 | 94 | Form 4 |
| 2026-06-10 | Tolda Stelleo | director | Gift | 250 | 75,590 | Form 4 |
| 2025-08-22 | Tolda Stelleo | director | Other acquisition | 20,000 | 20,000 | Form 4 |
| 2025-08-22 | Tolda Stelleo | director | Other acquisition | 20,000 | 0 | Form 4 |
| 2025-08-22 | Tolda Stelleo | director | Other acquisition | 20,000 | 20,000 | Form 4 |
| 2025-08-22 | Tolda Stelleo | director | Other acquisition | 20,000 | 0 | Form 4 |
| 2025-08-07 | Sanders Richard A | director | Award / grant | 64 | 414 | Form 4 |
| 2025-08-07 | Tolda Stelleo | director | Award / grant | 8 | 2,029 | Form 4 |
| 2025-08-07 | Tolda Stelleo | director | Award / grant | 64 | 64 | Form 4 |
| 2025-08-07 | Dubugras Henrique Vasoncelos | director | Award / grant | 64 | 64 | Form 4 |
| 2025-08-07 | Calemzuk Emiliano | director | Award / grant | 64 | 302 | Form 4 |
| 2025-08-07 | Lawson Martin R | director | Award / grant | 64 | 4,136 | Form 4 |
| 2025-08-07 | SEGAL SUSAN | director | Award / grant | 64 | 64 | Form 4 |
| 2025-08-07 | Aguzin Alejandro Nicolas | director | Award / grant | 64 | 4,755 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.